Kjellson Nina S
Insider CIK 1381980 · ELOX Director · GKOS 10% owner · OCRX Director · EIGR Director, 10% owner · CBYL 10% owner · TSRX Director · IVTY 10% owner · MKTO 10% owner · TSRO 10% owner · CDTX Director · TYRA Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ELOX Eloxx Pharmaceuticals, Inc | A Award deriv | 2026-06-08 | 2026-06-10 | 13,587 | — | $0 | 13,587 | SEC↗ |
| TYRA Tyra Biosciences, Inc. | S Sale | 2025-02-05 | 2025-02-07 | 3,511 | $13.76 | $48.3K | 443,885 | SEC↗ |
| TYRA Tyra Biosciences, Inc. | S Sale | 2025-02-05 | 2025-02-07 | 1,890 | $13.76 | $26.0K | 3,700,705 | SEC↗ |
| TYRA Tyra Biosciences, Inc. | S Sale | 2025-01-23 | 2025-01-27 | 4,825 | $16.26 | $78.5K | 3,702,595 | SEC↗ |
| TYRA Tyra Biosciences, Inc. | S Sale | 2025-01-21 | 2025-01-21 | 3,993 | $16.36 | $65.3K | 3,707,420 | SEC↗ |
| TYRA Tyra Biosciences, Inc. | S Sale | 2025-01-17 | 2025-01-21 | 12,808 | $16.40 | $210.1K | 3,711,413 | SEC↗ |
| TYRA Tyra Biosciences, Inc. | S Sale | 2025-01-17 | 2025-01-21 | 461 | $16.40 | $7.6K | 447,396 | SEC↗ |
| TYRA Tyra Biosciences, Inc. | S Sale | 2025-01-16 | 2025-01-21 | 835 | $16.29 | $13.6K | 447,857 | SEC↗ |
| TYRA Tyra Biosciences, Inc. | S Sale | 2025-01-16 | 2025-01-21 | 6,944 | $16.29 | $113.1K | 3,724,221 | SEC↗ |
| TYRA Tyra Biosciences, Inc. | S Sale | 2024-11-25 | 2024-11-26 | 566 | $16.84 | $9.5K | 448,692 | SEC↗ |
| TYRA Tyra Biosciences, Inc. | S Sale | 2024-11-25 | 2024-11-26 | 4,706 | $16.84 | $79.2K | 3,731,165 | SEC↗ |
| TYRA Tyra Biosciences, Inc. | S Sale | 2024-11-07 | 2024-11-08 | 19,720 | $17.32 | $341.6K | 3,735,871 | SEC↗ |
| TYRA Tyra Biosciences, Inc. | S Sale | 2024-11-07 | 2024-11-08 | 2,371 | $17.32 | $41.1K | 449,258 | SEC↗ |
| TYRA Tyra Biosciences, Inc. | S Sale | 2024-11-06 | 2024-11-08 | 5,635 | $17.18 | $96.8K | 451,629 | SEC↗ |
| TYRA Tyra Biosciences, Inc. | S Sale | 2024-11-06 | 2024-11-08 | 46,856 | $17.18 | $805.0K | 3,755,591 | SEC↗ |
| TYRA Tyra Biosciences, Inc. | S Sale | 2024-11-05 | 2024-11-06 | 1,126 | $16.77 | $18.9K | 457,264 | SEC↗ |
| TYRA Tyra Biosciences, Inc. | S Sale | 2024-11-05 | 2024-11-06 | 9,367 | $16.77 | $157.1K | 3,802,447 | SEC↗ |
| TYRA Tyra Biosciences, Inc. | S Sale | 2024-11-04 | 2024-11-06 | 116 | $17.01 | $2.0K | 458,390 | SEC↗ |
| TYRA Tyra Biosciences, Inc. | S Sale | 2024-11-04 | 2024-11-06 | 960 | $17.01 | $16.3K | 3,811,814 | SEC↗ |
| TYRA Tyra Biosciences, Inc. | S Sale | 2024-11-01 | 2024-11-01 | 604 | $17.16 | $10.4K | 3,812,774 | SEC↗ |
| TYRA Tyra Biosciences, Inc. | S Sale | 2024-11-01 | 2024-11-01 | 2,878 | $16.54 | $47.6K | 458,579 | SEC↗ |
| TYRA Tyra Biosciences, Inc. | S Sale | 2024-11-01 | 2024-11-01 | 23,938 | $16.54 | $395.9K | 3,813,378 | SEC↗ |
| TYRA Tyra Biosciences, Inc. | S Sale | 2024-11-01 | 2024-11-01 | 73 | $17.16 | $1.3K | 458,506 | SEC↗ |
| TYRA Tyra Biosciences, Inc. | S Sale | 2024-10-31 | 2024-11-01 | 89,390 | $16.46 | $1.47M | 3,837,316 | SEC↗ |
| TYRA Tyra Biosciences, Inc. | S Sale | 2024-10-31 | 2024-11-01 | 10,750 | $16.46 | $176.9K | 461,457 | SEC↗ |
| TYRA Tyra Biosciences, Inc. | S Sale | 2024-10-30 | 2024-11-01 | 9,889 | $16.17 | $159.9K | 3,926,706 | SEC↗ |
| TYRA Tyra Biosciences, Inc. | S Sale | 2024-10-30 | 2024-11-01 | 1,189 | $16.17 | $19.2K | 472,207 | SEC↗ |
| TYRA Tyra Biosciences, Inc. | A Award deriv | 2024-05-29 | 2024-05-31 | 18,600 | — | $0 | 18,600 | SEC↗ |
| TYRA Tyra Biosciences, Inc. | A Award deriv | 2023-05-31 | 2023-06-02 | 14,500 | — | $0 | 14,500 | SEC↗ |
| TYRA Tyra Biosciences, Inc. | A Award deriv | 2022-06-13 | 2022-06-15 | 14,500 | — | $0 | 14,500 | SEC↗ |
| TYRA Tyra Biosciences, Inc. | C Conversion deriv | 2021-09-17 | 2021-09-17 | 182,258 | — | $0 | 0 | SEC↗ |
| TYRA Tyra Biosciences, Inc. | C Conversion deriv | 2021-09-17 | 2021-09-17 | 182,257 | — | $0 | 0 | SEC↗ |
| TYRA Tyra Biosciences, Inc. | C Conversion deriv | 2021-09-17 | 2021-09-17 | 1,333,334 | — | $0 | 0 | SEC↗ |
| TYRA Tyra Biosciences, Inc. | C Conversion deriv | 2021-09-17 | 2021-09-20 | 1,333,334 | — | $0 | 0 | SEC↗ |
| TYRA Tyra Biosciences, Inc. | C Conversion deriv | 2021-09-17 | 2021-09-20 | 182,257 | — | $0 | 0 | SEC↗ |
| TYRA Tyra Biosciences, Inc. | C Conversion deriv | 2021-09-17 | 2021-09-20 | 182,258 | — | $0 | 0 | SEC↗ |
| TYRA Tyra Biosciences, Inc. | C Conversion | 2021-09-17 | 2021-09-17 | 473,396 | — | $0 | 473,396 | SEC↗ |
| TYRA Tyra Biosciences, Inc. | C Conversion | 2021-09-17 | 2021-09-17 | 3,936,595 | — | $0 | 3,963,595 | SEC↗ |
| TYRA Tyra Biosciences, Inc. | C Conversion | 2021-09-17 | 2021-09-20 | 473,396 | — | $0 | 473,396 | SEC↗ |
| TYRA Tyra Biosciences, Inc. | C Conversion | 2021-09-17 | 2021-09-20 | 3,936,595 | — | $0 | 3,936,595 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | D To issuer deriv | 2017-12-11 | 2017-12-11 | 12,500 | — | $0 | 0 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | D To issuer deriv | 2017-12-11 | 2017-12-11 | 10,000 | — | $0 | 0 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | D To issuer deriv | 2017-12-11 | 2017-12-11 | 10,000 | — | $0 | 0 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | D To issuer deriv | 2017-12-11 | 2017-12-11 | 20,000 | — | $0 | 0 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | D To issuer | 2017-12-11 | 2017-12-11 | 12,500 | $1.52 | $19.0K | 0 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | A Award | 2017-06-20 | 2017-06-22 | 12,500 | — | $0 | 12,500 | SEC↗ |
| EIGR Eiger BioPharmaceuticals, | A Award deriv | 2017-04-12 | 2017-04-14 | 10,000 | — | $0 | 10,000 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | A Award deriv | 2016-06-14 | 2016-06-15 | 12,500 | — | $0 | 12,500 | SEC↗ |
| EIGR Eiger BioPharmaceuticals, | A Award deriv | 2016-03-28 | 2016-09-15 | 25,000 | — | $0 | 25,000 | SEC↗ |
| EIGR Eiger BioPharmaceuticals, | A Award deriv | 2016-03-28 | 2016-04-01 | 25,000 | — | $0 | 25,000 | SEC↗ |
| GKOS GLAUKOS Corp | C Conversion deriv | 2015-06-30 | 2015-06-30 | 674,510 | — | $0 | 0 | SEC↗ |
| GKOS GLAUKOS Corp | C Conversion deriv | 2015-06-30 | 2015-06-30 | 151,653 | — | $0 | 0 | SEC↗ |
| GKOS GLAUKOS Corp | C Conversion deriv | 2015-06-30 | 2015-06-30 | 253,390 | — | $0 | 0 | SEC↗ |
| GKOS GLAUKOS Corp | C Conversion deriv | 2015-06-30 | 2015-06-30 | 1,523,809 | — | $0 | 0 | SEC↗ |
| GKOS GLAUKOS Corp | C Conversion | 2015-06-30 | 2015-06-30 | 2,603,362 | — | $0 | 2,603,362 | SEC↗ |
| IVTY Invuity, Inc. | C Conversion deriv | 2015-06-18 | 2015-06-22 | 712,291 | — | $0 | 0 | SEC↗ |
| IVTY Invuity, Inc. | C Conversion deriv | 2015-06-18 | 2015-06-22 | 56,368 | — | $0 | 0 | SEC↗ |
| IVTY Invuity, Inc. | C Conversion deriv | 2015-06-18 | 2015-06-22 | 262,310 | — | $0 | 0 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | A Award deriv | 2015-06-18 | 2015-06-22 | 10,000 | — | $0 | 10,000 | SEC↗ |
| IVTY Invuity, Inc. | C Conversion | 2015-06-18 | 2015-06-22 | 1,080,272 | — | $0 | 1,080,272 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | C Conversion deriv | 2015-04-20 | 2015-04-22 | 1,156,813 | — | $0 | 0 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | C Conversion | 2015-04-20 | 2015-04-22 | 1,156,813 | — | $0 | 1,356,813 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | P Buy | 2015-04-20 | 2015-04-22 | 200,000 | $16.00 | $3.20M | 200,000 | SEC↗ |
| CBYL Carbylan Therapeutics, Inc | C Conversion deriv | 2015-04-14 | 2015-04-14 | 466,357 | — | $0 | 0 | SEC↗ |
| CBYL Carbylan Therapeutics, Inc | C Conversion deriv | 2015-04-14 | 2015-04-14 | 365,957 | — | $0 | 0 | SEC↗ |
| CBYL Carbylan Therapeutics, Inc | C Conversion deriv | 2015-04-14 | 2015-04-14 | 2,145,351 | — | $0 | 0 | SEC↗ |
| CBYL Carbylan Therapeutics, Inc | C Conversion deriv | 2015-04-14 | 2015-04-14 | 831,531 | — | $0 | 0 | SEC↗ |
| CBYL Carbylan Therapeutics, Inc | P Buy | 2015-04-14 | 2015-04-14 | 810,000 | $5.00 | $4.05M | 4,619,196 | SEC↗ |
| CBYL Carbylan Therapeutics, Inc | C Conversion | 2015-04-14 | 2015-04-14 | 365,957 | — | $0 | 3,809,196 | SEC↗ |
| CBYL Carbylan Therapeutics, Inc | C Conversion | 2015-04-14 | 2015-04-14 | 466,357 | — | $0 | 3,443,239 | SEC↗ |
| CBYL Carbylan Therapeutics, Inc | C Conversion | 2015-04-14 | 2015-04-14 | 2,145,351 | — | $0 | 2,976,882 | SEC↗ |
| CBYL Carbylan Therapeutics, Inc | C Conversion | 2015-04-14 | 2015-04-14 | 831,531 | — | $0 | 831,531 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | A Award deriv | 2014-06-11 | 2014-06-13 | 10,000 | — | $0 | 10,000 | SEC↗ |
| MKTO Marketo, Inc. | S Sale | 2014-05-30 | 2014-06-02 | 19,373 | $23.20 | $449.5K | 0 | SEC↗ |
| MKTO Marketo, Inc. | S Sale | 2014-05-30 | 2014-06-02 | 1,034 | $24.16 | $25.0K | 49,266 | SEC↗ |
| MKTO Marketo, Inc. | S Sale | 2014-05-30 | 2014-06-02 | 16,613 | $23.06 | $383.1K | 0 | SEC↗ |
| MKTO Marketo, Inc. | S Sale | 2014-05-29 | 2014-06-02 | 9,118 | $24.56 | $223.9K | 0 | SEC↗ |
| MKTO Marketo, Inc. | S Sale | 2014-05-29 | 2014-06-02 | 11,298 | $24.59 | $277.8K | 0 | SEC↗ |
| MKTO Marketo, Inc. | S Sale | 2014-05-29 | 2014-06-02 | 21,821 | $24.58 | $536.4K | 19,373 | SEC↗ |
| MKTO Marketo, Inc. | S Sale | 2014-05-29 | 2014-06-02 | 22,090 | $24.57 | $542.8K | 16,613 | SEC↗ |
| MKTO Marketo, Inc. | S Sale | 2014-05-29 | 2014-06-02 | 23,133 | $24.57 | $568.4K | 50,300 | SEC↗ |
| MKTO Marketo, Inc. | J Other | 2014-05-28 | 2014-05-30 | 8,532 | — | $0 | 30,204 | SEC↗ |
| MKTO Marketo, Inc. | J Other | 2014-05-28 | 2014-05-30 | 974,000 | — | $0 | 3,715,756 | SEC↗ |
| MKTO Marketo, Inc. | J Other | 2014-05-28 | 2014-05-30 | 194,800 | — | $0 | 194,800 | SEC↗ |
| MKTO Marketo, Inc. | J Other | 2014-05-28 | 2014-05-30 | 194,800 | — | $0 | 0 | SEC↗ |
| MKTO Marketo, Inc. | J Other | 2014-05-28 | 2014-05-30 | 10,933 | — | $0 | 38,703 | SEC↗ |
| MKTO Marketo, Inc. | J Other | 2014-05-28 | 2014-05-30 | 11,298 | — | $0 | 11,298 | SEC↗ |
| MKTO Marketo, Inc. | J Other | 2014-05-28 | 2014-05-30 | 9,118 | — | $0 | 9,118 | SEC↗ |
| MKTO Marketo, Inc. | J Other | 2014-05-28 | 2014-05-30 | 25,597 | — | $0 | 41,194 | SEC↗ |
| MKTO Marketo, Inc. | J Other | 2014-05-28 | 2014-05-30 | 34,130 | — | $0 | 120,819 | SEC↗ |
| MKTO Marketo, Inc. | J Other | 2014-05-28 | 2014-05-30 | 26,393 | — | $0 | 73,433 | SEC↗ |
| MKTO Marketo, Inc. | S Sale | 2014-05-21 | 2014-05-22 | 5,000 | $24.00 | $120.0K | 15,597 | SEC↗ |
| MKTO Marketo, Inc. | S Sale | 2014-05-20 | 2014-05-22 | 5,000 | $24.02 | $120.1K | 20,597 | SEC↗ |
| MKTO Marketo, Inc. | S Sale | 2014-05-16 | 2014-05-20 | 15,000 | $22.96 | $344.4K | 25,597 | SEC↗ |
| MKTO Marketo, Inc. | S Sale | 2014-05-14 | 2014-05-15 | 8,463 | $24.34 | $206.0K | 0 | SEC↗ |
| MKTO Marketo, Inc. | S Sale | 2014-05-13 | 2014-05-15 | 14,695 | $24.26 | $356.5K | 8,463 | SEC↗ |
| MKTO Marketo, Inc. | S Sale | 2014-05-13 | 2014-05-15 | 11,298 | $24.25 | $274.0K | 0 | SEC↗ |
| MKTO Marketo, Inc. | J Other | 2014-05-12 | 2014-05-14 | 194,800 | — | $0 | 0 | SEC↗ |
| MKTO Marketo, Inc. | J Other | 2014-05-12 | 2014-05-14 | 8,532 | — | $0 | 21,672 | SEC↗ |
| MKTO Marketo, Inc. | J Other | 2014-05-12 | 2014-05-14 | 9,118 | — | $0 | 23,158 | SEC↗ |
| MKTO Marketo, Inc. | J Other | 2014-05-12 | 2014-05-14 | 25,597 | — | $0 | 40,597 | SEC↗ |
| MKTO Marketo, Inc. | J Other | 2014-05-12 | 2014-05-14 | 194,800 | — | $0 | 194,800 | SEC↗ |
| MKTO Marketo, Inc. | J Other | 2014-05-12 | 2014-05-14 | 974,000 | — | $0 | 4,689,756 | SEC↗ |
| MKTO Marketo, Inc. | J Other | 2014-05-12 | 2014-05-14 | 34,130 | — | $0 | 86,689 | SEC↗ |
| MKTO Marketo, Inc. | J Other | 2014-05-12 | 2014-05-14 | 26,393 | — | $0 | 47,040 | SEC↗ |
| MKTO Marketo, Inc. | J Other | 2014-05-12 | 2014-05-14 | 10,933 | — | $0 | 27,770 | SEC↗ |
| MKTO Marketo, Inc. | J Other | 2014-05-12 | 2014-05-14 | 11,298 | — | $0 | 11,298 | SEC↗ |
| MKTO Marketo, Inc. | S Sale | 2014-02-28 | 2014-03-03 | 5,000 | $41.56 | $207.8K | 15,000 | SEC↗ |
| MKTO Marketo, Inc. | S Sale | 2014-02-27 | 2014-03-03 | 19,420 | $42.06 | $816.8K | 20,000 | SEC↗ |
| MKTO Marketo, Inc. | S Sale | 2014-02-26 | 2014-02-28 | 13,050 | $40.03 | $522.4K | 0 | SEC↗ |
| MKTO Marketo, Inc. | S Sale | 2014-02-26 | 2014-02-28 | 20,000 | $40.62 | $812.4K | 20,647 | SEC↗ |
| MKTO Marketo, Inc. | J Other | 2014-02-25 | 2014-02-27 | 12,628 | — | $0 | 16,837 | SEC↗ |
| MKTO Marketo, Inc. | J Other | 2014-02-25 | 2014-02-27 | 29,565 | — | $0 | 39,420 | SEC↗ |
| MKTO Marketo, Inc. | J Other | 2014-02-25 | 2014-02-27 | 39,420 | — | $0 | 52,559 | SEC↗ |
| MKTO Marketo, Inc. | J Other | 2014-02-25 | 2014-02-27 | 30,485 | — | $0 | 40,647 | SEC↗ |
| MKTO Marketo, Inc. | J Other | 2014-02-25 | 2014-02-27 | 225,000 | — | $0 | 0 | SEC↗ |
| MKTO Marketo, Inc. | J Other | 2014-02-25 | 2014-02-27 | 225,000 | — | $0 | 225,000 | SEC↗ |
| MKTO Marketo, Inc. | J Other | 2014-02-25 | 2014-02-27 | 1,500,000 | — | $0 | 5,663,756 | SEC↗ |
| MKTO Marketo, Inc. | J Other | 2014-02-25 | 2014-02-27 | 13,050 | — | $0 | 13,050 | SEC↗ |
| MKTO Marketo, Inc. | J Other | 2014-02-25 | 2014-02-27 | 10,530 | — | $0 | 14,040 | SEC↗ |
| MKTO Marketo, Inc. | J Other | 2014-02-25 | 2014-02-27 | 9,855 | — | $0 | 13,140 | SEC↗ |
| MKTO Marketo, Inc. | S Sale | 2014-02-13 | 2014-02-18 | 4,350 | $40.70 | $177.0K | 0 | SEC↗ |
| MKTO Marketo, Inc. | J Other | 2014-02-12 | 2014-02-14 | 13,139 | — | $0 | 13,139 | SEC↗ |
| MKTO Marketo, Inc. | J Other | 2014-02-12 | 2014-02-14 | 3,285 | — | $0 | 3,285 | SEC↗ |
| MKTO Marketo, Inc. | J Other | 2014-02-12 | 2014-02-14 | 3,510 | — | $0 | 3,510 | SEC↗ |
| MKTO Marketo, Inc. | J Other | 2014-02-12 | 2014-02-14 | 10,162 | — | $0 | 10,162 | SEC↗ |
| MKTO Marketo, Inc. | J Other | 2014-02-12 | 2014-02-14 | 500,000 | — | $0 | 7,163,756 | SEC↗ |
| MKTO Marketo, Inc. | J Other | 2014-02-12 | 2014-02-14 | 75,000 | — | $0 | 75,000 | SEC↗ |
| MKTO Marketo, Inc. | J Other | 2014-02-12 | 2014-02-14 | 9,855 | — | $0 | 9,855 | SEC↗ |
| MKTO Marketo, Inc. | J Other | 2014-02-12 | 2014-02-14 | 75,000 | — | $0 | 0 | SEC↗ |
| MKTO Marketo, Inc. | J Other | 2014-02-12 | 2014-02-14 | 4,209 | — | $0 | 4,209 | SEC↗ |
| MKTO Marketo, Inc. | J Other | 2014-02-12 | 2014-02-14 | 4,350 | — | $0 | 4,350 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | P Buy deriv | 2013-11-08 | 2013-11-12 | 84,448 | — | $0 | 84,448 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | P Buy | 2013-11-08 | 2013-11-12 | 422,238 | — | $0 | 1,248,064 | SEC↗ |
| MKTO Marketo, Inc. | S Sale | 2013-09-18 | 2013-09-18 | 2,083,435 | $33.99 | $70.82M | 7,663,756 | SEC↗ |
| TSRX Trius Therapeutics Inc | D To issuer deriv | 2013-09-11 | 2013-09-13 | 12,000 | $5.24 | $62.9K | 0 | SEC↗ |
| TSRX Trius Therapeutics Inc | D To issuer deriv | 2013-09-11 | 2013-09-13 | 9,302 | $12.21 | $113.6K | 0 | SEC↗ |
| TSRX Trius Therapeutics Inc | D To issuer deriv | 2013-09-11 | 2013-09-13 | 15,000 | $5.73 | $86.0K | 0 | SEC↗ |
| TSRX Trius Therapeutics Inc | D To issuer deriv | 2013-09-11 | 2013-09-13 | 12,000 | $8.45 | $101.4K | 0 | SEC↗ |
| TSRX Trius Therapeutics Inc | D To issuer deriv | 2013-09-11 | 2013-09-13 | 12,000 | $10.00 | $120.0K | 0 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | A Award deriv | 2013-08-30 | 2013-12-23 | 20,000 | — | $0 | 20,000 | SEC↗ |
| TSRO TESARO, Inc. | J Other | 2013-08-05 | 2013-08-07 | 600,000 | — | $0 | 2,471,701 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | A Award deriv | 2013-07-15 | 2013-07-17 | 2,992 | — | $0 | 2,992 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | A Award deriv | 2013-07-15 | 2013-07-17 | 2,992 | — | $0 | 2,992 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | A Award deriv | 2013-07-15 | 2013-07-17 | 11,969 | — | $0 | 11,969 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | A Award deriv | 2013-07-15 | 2013-07-17 | 5,157 | — | $0 | 5,157 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | A Award deriv | 2013-07-15 | 2013-07-17 | 5,157 | — | $0 | 5,157 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | P Buy | 2013-07-15 | 2013-07-17 | 431,435 | $6.03 | $2.60M | 825,826 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | A Award | 2013-07-15 | 2013-07-17 | 394,391 | — | $0 | 394,391 | SEC↗ |
| MKTO Marketo, Inc. | C Conversion deriv | 2013-05-22 | 2013-05-22 | 227,272 | — | $0 | 0 | SEC↗ |
| MKTO Marketo, Inc. | C Conversion deriv | 2013-05-22 | 2013-05-22 | 394,714 | — | $0 | 0 | SEC↗ |
| MKTO Marketo, Inc. | C Conversion deriv | 2013-05-22 | 2013-05-22 | 570,977 | — | $0 | 0 | SEC↗ |
| MKTO Marketo, Inc. | C Conversion deriv | 2013-05-22 | 2013-05-22 | 3,154,228 | — | $0 | 0 | SEC↗ |
| MKTO Marketo, Inc. | C Conversion deriv | 2013-05-22 | 2013-05-22 | 5,400,000 | — | $0 | 0 | SEC↗ |
| MKTO Marketo, Inc. | C Conversion | 2013-05-22 | 2013-05-22 | 9,747,191 | — | $0 | 9,747,191 | SEC↗ |
| TSRX Trius Therapeutics Inc | A Award deriv | 2013-05-21 | 2013-05-23 | 15,000 | — | $0 | 15,000 | SEC↗ |
| TSRO TESARO, Inc. | C Conversion deriv | 2012-07-03 | 2012-07-05 | 9,195,402 | — | $0 | 0 | SEC↗ |
| TSRO TESARO, Inc. | C Conversion | 2012-07-03 | 2012-07-05 | 2,627,257 | — | $0 | 2,627,257 | SEC↗ |
| TSRO TESARO, Inc. | P Buy | 2012-07-03 | 2012-07-05 | 444,444 | $13.50 | $6.00M | 3,071,701 | SEC↗ |
| TSRX Trius Therapeutics Inc | A Award deriv | 2012-05-22 | 2012-05-24 | 12,000 | — | $0 | 12,000 | SEC↗ |